| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,310 |
3,251 |
$260K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,191 |
4,100 |
$211K |
| 99051 |
|
6,715 |
6,547 |
$188K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
882 |
873 |
$84K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
334 |
331 |
$46K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
703 |
700 |
$27K |
| 87428 |
|
563 |
561 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,141 |
569 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
916 |
906 |
$13K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
62 |
61 |
$2K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
33 |
32 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
59 |
57 |
$0.00 |